Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com admin Website Prev Post Operational Update June 4, 2025 Next Post Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines June 4, 2025 Related Posts Retraction of Lo Herma Scoping Study Statements June 6, 2025 Metals Focus: Gold to Average US$3,210 in 2025 as Central Banks Buy and Trade Tensions Grow June 6, 2025 Prismo Metals Appoints Gordon Aldcorn as President June 6, 2025
Metals Focus: Gold to Average US$3,210 in 2025 as Central Banks Buy and Trade Tensions Grow June 6, 2025